相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Hold on or Cut? Integrin- and MMP-Mediated Cell-Matrix Interactions in the Tumor Microenvironment
Stephan Niland et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis
Hanfang Jiang et al.
BMC CANCER (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Cancer statistics for the year 2020: An overview
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy
Iris Lodewijk et al.
CLINICAL EPIGENETICS (2021)
Current Perspectives on the Role of Matrix Metalloproteinases in the Pathogenesis of Basal Cell Carcinoma
Mircea Tampa et al.
BIOMOLECULES (2021)
Matrix metalloproteases and TIMPs as prognostic biomarkers in breast cancer patients treated with radiotherapy: A pilot study
Maria Auxiliadora Olivares-Urbano et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Breast cancer models: Engineering the tumor microenvironment
Gokhan Bahcecioglu et al.
ACTA BIOMATERIALIA (2020)
Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma
Salvatore Napoli et al.
CELLS (2020)
Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?
Silvia Vivarelli et al.
CANCERS (2020)
Abnormal Hypermethylation of CpG Dinucleotides in Promoter Regions of Matrix Metalloproteinases Genes in Breast Cancer and its Relation to Epigenomic Subtypes and HER2 Overexpression
Olga A. Simonova et al.
BIOMEDICINES (2020)
The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
Camille Maringe et al.
LANCET ONCOLOGY (2020)
Identification of Modulated MicroRNAs Associated with Breast Cancer, Diet, and Physical Activity
Luca Falzone et al.
CANCERS (2020)
The Extracellular Matrix and Vesicles Modulate the Breast Tumor Microenvironment
Jun Yang et al.
BIOENGINEERING-BASEL (2020)
A case-control study of Metallothionein-1 expression in breast cancer and breast fibroadenoma
Fabiane Araujo Sampaio et al.
SCIENTIFIC REPORTS (2019)
The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis
Mahsa Javadian et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
MMP-1 is overexpressed in triple-negative breast cancer tissues and the knockdown of MMP-1 expression inhibits tumor cell malignant behaviors in vitro
Qi-Min Wang et al.
ONCOLOGY LETTERS (2019)
Expression of matrix metalloproteinase 2 and 9 in breast cancer and breast fibroadenoma: a randomized, double-blind study
Luana Mota Martins et al.
Oncotarget (2019)
MiR-519d suppresses breast cancer tumorigenesis and metastasis via targeting MMP3
Chengling Chu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes
Arthur Winer et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Cutting to the Chase: How Matrix Metalloproteinase-2 Activity Controls Breast-Cancer-to-Bone Metastasis
Marilena Tauro et al.
CANCERS (2018)
Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer
Evette S. Radisky et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis
Ji Wang et al.
ONCOTARGET (2017)
MMP1 expression is activated by Slug and enhances multi-drug resistance (MDR) in breast cancer
Ching-Ju Shen et al.
PLOS ONE (2017)
Matrix metalloproteinases as breast cancer drivers and therapeutic targets
Evette S. Radisky et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2015)
Is there new hope for therapeutic matrix metalloproteinase inhibition?
Roosmarijn E. Vandenbroucke et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility
Edyta Wieczorek et al.
BJU INTERNATIONAL (2013)
miRNAs regulate expression and function of extracellular matrix molecules
Zina Jeyapalan Rutnam et al.
MATRIX BIOLOGY (2013)
The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model
Hui Liu et al.
BMC CANCER (2012)
The extracellular matrix: A dynamic niche in cancer progression
Pengfei Lu et al.
JOURNAL OF CELL BIOLOGY (2012)
Matrix metalloproteinases: Potential therapy to prevent the development of second malignancies after breast radiotherapy
F. Artacho-Cordon et al.
SURGICAL ONCOLOGY-OXFORD (2012)
MMP-1 expression has an independent prognostic value in breast cancer
Pia Bostrom et al.
BMC CANCER (2011)
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Chrisostomi Gialeli et al.
FEBS JOURNAL (2011)
Mechanisms of cancer cell metastasis to the bone: a multistep process
Lalit R. Patel et al.
FUTURE ONCOLOGY (2011)
Correlation Between MMP1-PAR1 Axis and Clinical Outcome of Primary Gallbladder Carcinoma
Xilin Du et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2011)
TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis
Yvette Drabsch et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2011)
Matrix metalloproteinases: What do they not do? New substrates and biological roles identified by murine models and proteomics
David Rodriguez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Stromelysin-1 (MMP-3) is a target and a regulator of Wnt1-induced epithelial-mesenchymal transition (EMT)
Laurence Blavier et al.
CANCER BIOLOGY & THERAPY (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
A MicroRNA Targeting Dicer for Metastasis Control
Graziano Martello et al.
CELL (2010)
MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression
Bao Song et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status
Martin Grimm et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Effect of microRNA-206 on cytoskeleton remodelling by downregulating Cdc42 in MDA-MB-231 cells
Hao Liu et al.
TUMORI JOURNAL (2010)
Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature
Andrea Koehrmann et al.
BMC CANCER (2009)
Matrix metalloproteinase and G protein coupled receptors: Co-conspirators in the pathogenesis of autoimmune disease and cancer
Sarah M. Eck et al.
JOURNAL OF AUTOIMMUNITY (2009)
Matrix Metalloproteinases As Novel Biomarkers and Potential Therapeutic Targets in Human Cancer
Roopali Roy et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Small-molecule inhibitors of microRNA miR-21 function
Kiranmai Gumireddy et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma
Shaoqiang Cheng et al.
JOURNAL OF SURGICAL RESEARCH (2008)
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
John A. Foekens et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Breast cancer progression: insights into multifaceted matrix metalloproteinases
Vincent Chabottaux et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Matrix metalloproteinases and tumor metastasis
EI Deryugina et al.
CANCER AND METASTASIS REVIEWS (2006)
Gelatinase-mediated migration and invasion of cancer cells
M Björklund et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2005)
Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma
BP Patel et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and etastasis
H Sato et al.
CANCER SCIENCE (2005)
The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone
K Holmbeck et al.
JOURNAL OF CELL SCIENCE (2005)
TIMPs as multifacial proteins
E Lambert et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
The role of gelatinases in colorectal cancer progression and metastasis
ORF Mook et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2004)
Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with special reference to activator protein-2, HER2, and prognosis
JM Pellikainen et al.
CLINICAL CANCER RESEARCH (2004)
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
A Sparmann et al.
CANCER CELL (2004)
Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1,-3, and-13 gene expression by multiplex PCR in colorectal carcinomas
E Roeb et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2004)
Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma
HC Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
LM Coussens et al.
SCIENCE (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion
AM Belkin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Stromelysin-1 regulates adipogenesis during mammary gland involution
CM Alexander et al.
JOURNAL OF CELL BIOLOGY (2001)
The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter
MD Sternlicht et al.
ONCOGENE (2000)
分享论文
